Abstract |
The year 2015 was punctuated by numerous events in diabetology. First, the ADA/EASD guidelines have been updated. The pharmacological panel for type 2 diabetes treatment saw the arrival of different new molecules. Two new basal insulins were also approved. Also, cardiovascular safety trials have been published regarding recent antidiabetic drugs. A new insulin pump than can be coupled with a glucosensor was released. Finally, a new unexpected complication of SGLT2 inhibitors treatment was reported, the euglycemic keto- acidosis.
|
Authors | François R Jornayvaz |
Journal | Revue medicale suisse
(Rev Med Suisse)
Vol. 12
Issue 500
Pg. 30-1
(Jan 13 2016)
ISSN: 1660-9379 [Print] Switzerland |
Vernacular Title | Diabétologie. |
PMID | 26946699
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Hypoglycemic Agents
- Insulins
|
Topics |
- Diabetes Mellitus, Type 2
(drug therapy)
- Humans
- Hypoglycemic Agents
(adverse effects, therapeutic use)
- Insulins
(administration & dosage)
- Practice Guidelines as Topic
|